IL37 and psoriasis: illustrated that both the ablation of miR-210 in mice and inhibition of miR-210 by intradermal injection of antagomir-210 block the immune imbalance and the development of psoriasis-like inflammation in an imiquimod-induced or IL-23-induced psoriasis-like mouse model.